DanielDiGiacomoMD

Allergy & Immunology • Neptune, NJ

Clinical & Laboratory Immunology

Allergist/Immunologist

Join to view full profile

Dr. DiGiacomo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. DiGiacomo's full profile

Already have an account?

Office
19 Davis Ave
Neptune, NJ 07753

Education & Training

Massachusetts General HospitalFellowship, Allergy and Immunology, 2020 - 2022
Children's National HospitalResidency, Pediatrics, 2017 - 2020
Tulane University School of MedicineClass of 2017
Columbia UniversityMPH, 2010 - 2012

Certifications & Licensure

MA State Medical License 2020 - 2025
NJ State Medical License 2023 - 2025
DC State Medical License 2017 - 2020
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Targeted treatment for activated phosphoinositide 3-kinase delta syndrome, CTLA-4 insufficiency, and STAT1 gain-of-function.
Rebecca R Saff, Daniel DiGiacomo
Annals of Allergy, Asthma & Immunology. 2024-11-27
4 citations
Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016-2023).
Angela E Lin, Eleanor R Scimone, Robyn P Thom, Duraisamy Balaguru, T Bernard Kinane
American Journal of Medical Genetics. Part A. 2024-10-01
1 citations
Renal complications in patients with predominantly antibody deficiency in the United States Immune Deficiency Network (USIDNET).
Emma Materne, Baijun Zhou, Daniel DiGiacomo, Jocelyn R Farmer, Ramsay Fuleihan
The Journal of Allergy and Clinical Immunology. 2024-07-01